Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy
NCT02155595 is an observational study sponsored by Henry Ford Health System. As of 21 Nov 2026, it is completed. It studies Atypical Femoral Fractures, Osteoporosis and 1 more condition. The registry lists an enrollment of 738 participants at 1 site in 1 country. The registry lists a start date of 31 May 2014 and a primary completion date of 31 Aug 2018.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02155595 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Henry Ford Health System |
| Enrollment | 738 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Atypical Femoral Fractures, Osteoporosis and Prodromal Bone Deterioration |
| Start | 31 May 2014 |
| Primary completion | 31 Aug 2018 |
| Study completion | 31 Aug 2018 |
| Last update posted | 29 Mar 2019 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Sudhaker D. Rao, M.B;B.S.
Henry Ford Health System
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Henry Ford Medical Center, New Center One
Detroit
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02155595
Each answer restates registry values shown on this page.
What is NCT02155595?
NCT02155595 is an observational study sponsored by Henry Ford Health System. It studies Atypical Femoral Fractures, Osteoporosis and 1 more condition.
Who leads NCT02155595?
The registry names Sudhaker D. Rao, M.B;B.S. (principal investigator, Henry Ford Health System) as the overall official.
Where does NCT02155595 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT02155595 end?
The registry lists a primary completion date of 31 Aug 2018 and a study completion date of 31 Aug 2018. The sponsor last updated the record on 29 Mar 2019.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.